Company / Operating Cash Flow
Emergent BioSolutions Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$170.6M
FY2025
5-year range
-$206.3M / $320.2M
FY2021-FY2025
Trend
+190.6%
vs FY2024
Sector context
#43 of 216
Health Care
What the data says
Emergent BioSolutions Inc.'s operating cash flow of $171M is higher than 80% of companies in the Health Care sector (FY2025). Operating Cash Flow has fluctuated over the past 10 years, ranging from -$206M in FY2023 to $536M in FY2020.
Based on SEC 10-K filings.
$171M in FY2025 with a 5-year CAGR of -20.5%. Top quartile in the Health Care sector.
Improved from -$206M to $171M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -20.5%
- 10-Year CAGR
- -
Sector benchmark
-74.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -20.5%, indicating a declining trend.
- In FY2025, operating cash flow increased 190.6% year-over-year.
- Ranks #43 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $170.6M | +190.6% |
| FY2024 | $58.7M | +128.5% |
| FY2023 | -$206.3M | -505.0% |
| FY2022 | -$34.1M | -110.6% |
| FY2021 | $320.2M | -40.3% |
| FY2020 | $536.0M | +185.1% |
| FY2019 | $188.0M | +244.3% |
| FY2018 | $54.6M | -73.8% |
| FY2017 | $208.1M | +281.1% |
| FY2016 | $54.6M | +28.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026